Author:
Schweikert H.U.,Tunn U.W.,Habenicht U.-F.,Arnold J.,Senge Th.,Schulze H.,Schröder F.H.,Blom J.H.M.,Ennemoser O.,Horniger W.,Bartsch G.
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference15 articles.
1. Human benign prostatic hyperplasia: etiological considerations;Walsh,1984
2. Results of surgical treatment of benign prostatic hyperplasia;Grayhack,1975
3. 1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis;Henderson;J. Steroid Biochem.,1986
4. Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-androstene-3,17-dione;Habenicht;The Prostate,1986
5. Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione;Habenicht;The Prostate,1987
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献